|
Proteintech
il1ra ![]() Il1ra, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/il1ra/product/Proteintech Average 94 stars, based on 1 article reviews
il1ra - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
Boster Bio
product ![]() Product, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/product/product/Boster Bio Average 92 stars, based on 1 article reviews
product - by Bioz Stars,
2026-02
92/100 stars
|
Buy from Supplier |
|
Genentech inc
il-1ra anakinra ![]() Il 1ra Anakinra, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/il-1ra anakinra/product/Genentech inc Average 90 stars, based on 1 article reviews
il-1ra anakinra - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Pasteur Institute
il-1r antagonist (il-1ra) anakinra ![]() Il 1r Antagonist (Il 1ra) Anakinra, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/il-1r antagonist (il-1ra) anakinra/product/Pasteur Institute Average 90 stars, based on 1 article reviews
il-1r antagonist (il-1ra) anakinra - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Proteostasis Therapeutics
recombinant il-1 receptor antagonist (il-1ra, anakinra) ![]() Recombinant Il 1 Receptor Antagonist (Il 1ra, Anakinra), supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/recombinant il-1 receptor antagonist (il-1ra, anakinra)/product/Proteostasis Therapeutics Average 90 stars, based on 1 article reviews
recombinant il-1 receptor antagonist (il-1ra, anakinra) - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Boster Bio
human il 1ra elisa kit ![]() Human Il 1ra Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human il 1ra elisa kit/product/Boster Bio Average 90 stars, based on 1 article reviews
human il 1ra elisa kit - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Translational oncology
Article Title: IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response.
doi: 10.1016/j.tranon.2025.102428
Figure Lengend Snippet: Fig. 2. Low expression of IL1RA in OSCC and validation of IL1RA overexpression efficiency. A. Expression levels of IL1RA in HNSCC and normal specimens available from the GEPIA database. B. H&E and IHC staining of OSCC and paracancerous specimens in vitro (n=50, scale bar=100 μm). The percentage of low and high IL1RA expressions in OSCC and paracancerous specimens is visualized. C-D. Efficiency of IL1RA overexpression by lentivirus transfection is validated in CAL27 and HN6 cells by RT-qPCR (C) and Western blot (D) in vitro. *P<0.05, and **P<0.01 vs. NC group.
Article Snippet: Transferring on the Polyvinylidene fluoride (PVDF) membrane, it was immersed in 5 % skim milk, and incubated overnight at 4◦C with primary antibodies against β-Actin (#3700, CST, 1:1000),
Techniques: Expressing, Biomarker Discovery, Over Expression, Immunohistochemistry, In Vitro, Transfection, Quantitative RT-PCR, Western Blot
Journal: Translational oncology
Article Title: IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response.
doi: 10.1016/j.tranon.2025.102428
Figure Lengend Snippet: Fig. 3. IL1RA inhibits the proliferation and migration of OSCC cells in vitro. CAL27 and HN6 cells were transfected with NC and oeIL1RA. A. Cell viability at 0, 24, 48, and 72 h was detected by CCK-8 assay. B. Clone number detected by colony formation assay. C. Cell migration was detected by the cell scratch assay at 0 and 24 h (scale bar=100 μm). *P<0.05, and **P<0.01 vs. NC group.
Article Snippet: Transferring on the Polyvinylidene fluoride (PVDF) membrane, it was immersed in 5 % skim milk, and incubated overnight at 4◦C with primary antibodies against β-Actin (#3700, CST, 1:1000),
Techniques: Migration, In Vitro, Transfection, CCK-8 Assay, Colony Assay, Wound Healing Assay
Journal: Translational oncology
Article Title: IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response.
doi: 10.1016/j.tranon.2025.102428
Figure Lengend Snippet: Fig. 4. IL1RA inhibits tumor growth in OSCC in vivo. Nude mice were subcutaneously implanted with 1 × 106 CAL27 cells transfected with NC and oeIL1RA. A. Gross view of OSCC xenografts at 21 days, and the mean tumor weight and volume. B. The mRNA level of IL1RA in OSCC xenografts of NC group and oeIL1RA group. C. H&E and IHC staining of OSCC xenografts in the NC group and oeIL1RA group (scale bar=100 μm). n=6. *P<0.05, and **P<0.01 vs. NC group.
Article Snippet: Transferring on the Polyvinylidene fluoride (PVDF) membrane, it was immersed in 5 % skim milk, and incubated overnight at 4◦C with primary antibodies against β-Actin (#3700, CST, 1:1000),
Techniques: In Vivo, Transfection, Immunohistochemistry
Journal: Translational oncology
Article Title: IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response.
doi: 10.1016/j.tranon.2025.102428
Figure Lengend Snippet: Fig. 5. IL1RA is associated with oncogenic signaling pathways and type I interferon response in OSCC in vitro. A. Volcano plots visualizing 132 DEGs between CAL27 cells transfected with NC and oeIL1RA. Down-regulated, up-regulated and non-regulated genes were labeled in blue, red, and grey colors, respectively. B. GSEA showed less enriched cancer-related features or processes in CAL27 cells overexpressing IL1RA. C. GSEA showed that IL1RA overexpression was significantly associated with the type I interferon response. D. A Venn diagram visualizing 45 (61.6 %) OSCC patients simultaneously carrying mutations in the IL1RA, IFNA, and IFNB genes in the TCGA dataset.
Article Snippet: Transferring on the Polyvinylidene fluoride (PVDF) membrane, it was immersed in 5 % skim milk, and incubated overnight at 4◦C with primary antibodies against β-Actin (#3700, CST, 1:1000),
Techniques: Protein-Protein interactions, In Vitro, Transfection, Labeling, Over Expression
Journal: Translational oncology
Article Title: IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response.
doi: 10.1016/j.tranon.2025.102428
Figure Lengend Snippet: Fig. 6. DEGs in OSCC cells overexpressing IL1RA are involved in multiple interferon response processes. A. GO enrichment analysis showed that over expression of IL1RA was associated with the type I interferon response in OSCC, with a positive correlation. B. The analysis in the Reactome Pathway Database showed that overexpression of IL1RA was associated with interferon signaling pathways, including the interferon α/βand interferon γ signaling pathways.
Article Snippet: Transferring on the Polyvinylidene fluoride (PVDF) membrane, it was immersed in 5 % skim milk, and incubated overnight at 4◦C with primary antibodies against β-Actin (#3700, CST, 1:1000),
Techniques: Over Expression, Protein-Protein interactions
Journal: Translational oncology
Article Title: IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response.
doi: 10.1016/j.tranon.2025.102428
Figure Lengend Snippet: Fig. 7. Overexpression of IL1RA up-regulates type I interferon proteins in OSCC in vitro. A. H&E (the first lane) and IHC staining (the latter three lanes) of IFNA and IFNB in OSCC specimens of the high and low IL1RA expression groups (n=30, scale bar=100 μm). B-C. The mRNA (B) and protein expressions (C) of IFNA and IFNB in OSCC specimens of the high and low IL1RA expression groups. *P<0.05, and **P<0.01 vs. NC group.
Article Snippet: Transferring on the Polyvinylidene fluoride (PVDF) membrane, it was immersed in 5 % skim milk, and incubated overnight at 4◦C with primary antibodies against β-Actin (#3700, CST, 1:1000),
Techniques: Over Expression, In Vitro, Immunohistochemistry, Expressing
Journal: Translational oncology
Article Title: IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response.
doi: 10.1016/j.tranon.2025.102428
Figure Lengend Snippet: Fig. 8. IL1RA promotes the expressions of IFNA and IFNB in the OSCC xenografts and their release in OSCC cells. A. IHC staining of positive expressions of IFNA and IFNB in OSCC xenografts of oeIL1RA group and NC group in vivo (scale bar=100 μm). B. The mRNA levels of IFNA and IFNB in OSCC xenografts of the oeIL1RA group and NC group in vivo. C. ELISA showed contents of IFNA and IFNB in the cell supernatant of the oeIL1RA group and NC group in vitro. *P<0.05, and **P<0.01 vs. NC group.
Article Snippet: Transferring on the Polyvinylidene fluoride (PVDF) membrane, it was immersed in 5 % skim milk, and incubated overnight at 4◦C with primary antibodies against β-Actin (#3700, CST, 1:1000),
Techniques: Immunohistochemistry, In Vivo, Enzyme-linked Immunosorbent Assay, In Vitro